Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest ...

Lilly is trying to stay ahead of rivals Novo Nordisk and Sanofi in an increasingly competitive insulin market, as well as tapping into the trend to make medicines safer and more effective through ...

Weight loss goals may be at the forefront of many New Year's resolutions, which could push the exuberance for Eli Lilly LLY and Novo Nordisk NVO stock. As the major players in the hyper-scale ...

Clarivate’s Drugs to Watch in 2025 report (PDF) predicts that Novo’s new once-weekly insulin Awiqli will pick ... Novo and Eli Lilly have been duking it out in the fields of diabetes and ...